This study investigates the in vitro antitumor activity of C. amuricus fractionated extracts against hepatocellular carcinoma cells, coupled with molecular docking analysis targeting key components of the PI3K/AKT/mTOR signaling axis. This evidence concerns the gene AKT1 and hepatocellular carcinoma.